MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cullinan Therapeutics (CGEM) Ownership - Who owns Cullinan Therapeutics?
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
452.64M
P/E Ratio
N/A
Total Cash
303.83M
Projected Growth
N/A
Total Debt
1.84M
Revenue
N/A
Risk (Beta)
-0.02
Dividend Yield
N/A
Total Cash/Share
5.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGEM
Capitalization
453M
P/E Ratio
N/A
Risk (Beta)
-0.02
Dividend Yield
N/A
Total Cash
304M
Total Cash/Share
5.15
Total Debt
1.84M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
552M
P/B Ratio
0.82
Cash Flow
N/A
Earnings
-2.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
11.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-208.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.74
Shares Held By Institutions
598M
Shares Outstanding - Current
59M
Total Liabilities
27.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.028
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com